Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3893589)

Published in BMC Gastroenterol on January 10, 2014

Authors

Mariana Ferreira Leal1, Tatiane Katsue Furuya Mazzotti, Danielle Queiroz Calcagno, Priscila Daniele Ramos Cirilo, Margarita Cortes Martinez, Samia Demachki, Paulo Pimentel Assumpção, Roger Chammas, Rommel Rodríguez Burbano, Marília Cardoso Smith

Author Affiliations

1: Genetics Division, Department of Morphology and Genetic, Federal University of São Paulo, R, Botucatu, 740, São Paulo, SP CEP 04023-900, Brazil. mariana.morf@epm.br.

Articles cited by this

Global cancer statistics. CA Cancer J Clin (2011) 185.92

A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61

THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65

Stochastic mRNA synthesis in mammalian cells. PLoS Biol (2006) 12.58

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41

Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol (2006) 9.95

Nucleophosmin and cancer. Nat Rev Cancer (2006) 4.82

Global signatures of protein and mRNA expression levels. Mol Biosyst (2009) 4.43

A comparison of selected mRNA and protein abundances in human liver. Electrophoresis (1997) 4.35

Role of nucleophosmin in embryonic development and tumorigenesis. Nature (2005) 4.09

Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol (1992) 3.97

Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol Cell (2003) 3.42

N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev (2004) 2.14

Nucleolar protein B23 has molecular chaperone activities. Protein Sci (1999) 2.07

Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem (2001) 1.89

Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? Blood (2010) 1.80

The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell (2002) 1.72

Protein abundances are more conserved than mRNA abundances across diverse taxa. Proteomics (2010) 1.71

Genetic pathways of two types of gastric cancer. IARC Sci Publ (2004) 1.71

NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling. Biochem Res Int (2010) 1.49

Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J Cell Biol (2008) 1.41

Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase. J Biol Chem (2004) 1.39

Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol (1996) 1.36

The role of nucleophosmin in centrosome duplication. Oncogene (2002) 1.26

Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res (1992) 1.24

Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate (1999) 1.20

MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol (2008) 1.17

Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol (2006) 1.14

Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36. J Cell Sci (2009) 1.14

Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability. J Biol Chem (2006) 1.13

Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig (1998) 1.10

Nucleophosmin: a versatile molecule associated with hematological malignancies. Cancer Sci (2006) 1.09

Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chem Biol Interact (2009) 1.08

Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol Pathol (2000) 1.07

Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer (2007) 1.07

C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res (2006) 1.06

A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication. Cell Cycle (2002) 1.06

MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res (2009) 1.05

Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res (2005) 1.02

Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma. Cancer Genet Cytogenet (2008) 0.98

Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology (2004) 0.98

Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics (2010) 0.97

MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One (2013) 0.96

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol (1998) 0.95

Numerical aberrations of chromosome 8 detected by conventional cytogenetics and fluorescence in situ hybridization in individuals from northern Brazil with gastric adenocarcinoma. Cancer Genet Cytogenet (2006) 0.93

Nucleophosmin may act as an alarmin: implications for severe sepsis. J Leukoc Biol (2009) 0.92

Expression of nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells. J Biomed Sci (2012) 0.91

Helicobacter pylori and cagA and vacA gene status in children from Brazil with chronic gastritis. Clin Exp Med (2003) 0.90

MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet (2010) 0.88

Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One (2012) 0.88

An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer. Am J Pathol (2011) 0.86

Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.85

Fine-tuning nucleophosmin in macrophage differentiation and activation. Blood (2011) 0.82

hTERT and TP53 deregulation in intestinal-type gastric carcinogenesis in non-human primates. Clin Exp Med (2012) 0.79

Articles by these authors

Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett (2009) 1.60

Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem (2008) 1.40

Interrelationship between chromosome 8 aneuploidy, C-MYC amplification and increased expression in individuals from northern Brazil with gastric adenocarcinoma. World J Gastroenterol (2006) 1.14

Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol (2006) 1.14

C-MYC locus amplification as metastasis predictor in intestinal-type gastric adenocarcinomas: CGH study in Brazil. Anticancer Res (2006) 1.06

Melanocyte transformation associated with substrate adhesion impediment. Neoplasia (2006) 1.06

MYC insertions in diffuse-type gastric adenocarcinoma. Anticancer Res (2009) 1.05

Epigenetic mechanisms in gastric cancer. Epigenomics (2012) 1.05

Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol (2009) 1.04

Emerging technologies in extracellular vesicle-based molecular diagnostics. Expert Rev Mol Diagn (2014) 1.04

Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma. Anticancer Res (2005) 1.02

MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. BMC Gastroenterol (2013) 1.01

Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. Int J Cancer (2005) 1.01

Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer (2010) 1.00

Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics (2006) 1.00

Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer (2010) 1.00

Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection. Am J Pathol (2007) 0.99

Interrelationship between MYC gene numerical aberrations and protein expression in individuals from northern Brazil with early gastric adenocarcinoma. Cancer Genet Cytogenet (2008) 0.98

Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics (2005) 0.98

ADAM23 negatively modulates alpha(v)beta(3) integrin activation during metastasis. Cancer Res (2009) 0.98

Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. Mediators Inflamm (2012) 0.97

Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics (2010) 0.97

MYC deregulation in gastric cancer and its clinicopathological implications. PLoS One (2013) 0.96

Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from North Brazil. Mem Inst Oswaldo Cruz (2006) 0.95

Reference genes for quantitative RT-PCR data in gastric tissues and cell lines. World J Gastroenterol (2013) 0.95

Establishment and conventional cytogenetic characterization of three gastric cancer cell lines. Cancer Genet Cytogenet (2009) 0.94

Titanium pigment in tissues of drug addicts: report of 5 necropsied cases. Rev Hosp Clin Fac Med Sao Paulo (2004) 0.94

Prognostic and predictive significance of MYC and KRAS alterations in breast cancer from women treated with neoadjuvant chemotherapy. PLoS One (2013) 0.94

Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb Haemost (2011) 0.93

Numerical aberrations of chromosome 8 detected by conventional cytogenetics and fluorescence in situ hybridization in individuals from northern Brazil with gastric adenocarcinoma. Cancer Genet Cytogenet (2006) 0.93

hTERT methylation and expression in gastric cancer. Biomarkers (2009) 0.93

Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection. Eur J Immunol (2008) 0.92

Helicobacter pylori in dental plaque and stomach of patients from Northern Brazil. World J Gastroenterol (2010) 0.92

Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemother Pharmacol (2009) 0.91

XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet (2008) 0.91

MYC, TP53, and chromosome 17 copy-number alterations in multiple gastric cancer cell lines and in their parental primary tumors. J Biomed Biotechnol (2011) 0.91

European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil. J Dermatol Sci (2011) 0.91

Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. World J Gastroenterol (2007) 0.90

Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells. Glycobiology (2009) 0.89

MYC in gastric carcinoma and intestinal metaplasia of young adults. Cancer Genet Cytogenet (2010) 0.88

Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization. Cancer Genet Cytogenet (2009) 0.88

Chromosome X aneuploidy in Brazilian schizophrenic patients. In Vivo (2010) 0.88

Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One (2012) 0.88

hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions. BMC Gastroenterol (2012) 0.88

Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS One (2009) 0.87

Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol (2012) 0.86

Interrelationship between TP53 gene deletion, protein expression and chromosome 17 aneusomy in gastric adenocarcinoma. BMC Gastroenterol (2009) 0.86

Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil. Anticancer Res (2010) 0.86

Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Arch Med Res (2007) 0.86

Galectin-3 negatively regulates the frequency and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells and influences the course of Leishmania major infection. Eur J Immunol (2013) 0.86

Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. Tumour Biol (2014) 0.85

Occurrence of Helicobacter pylori and Epstein-Barr virus infection in endoscopic and gastric cancer patients from Northern Brazil. BMC Gastroenterol (2014) 0.85

Activation of the Wnt/beta-catenin signaling pathway during oral carcinogenesis process is not influenced by the absence of galectin-3 in mice. Anticancer Res (2011) 0.85

Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early Toxoplasma gondii infection. Immunobiology (2009) 0.85

Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking. Int J Dev Biol (2011) 0.85

Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. Cancer Med (2014) 0.85

NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis. Cancer Immunol Immunother (2011) 0.84

Galectin-3 modulates carbohydrate-dependent thymocyte interactions with the thymic microenvironment. Eur J Immunol (2002) 0.84

Low frequency of human papillomavirus detection in prostate tissue from individuals from Northern Brazil. Mem Inst Oswaldo Cruz (2009) 0.84

Endostatin neoadjuvant gene therapy extends survival in an orthotopic metastatic mouse model of renal cell carcinoma. Biomed Pharmacother (2011) 0.84